Starting a GLP-1 During Perimenopause When You're Already on a Mood Medication

If you are in your 40s or 50s, already taking something for your mood, and now thinking about a GLP-1 for weight, you are asking a more layered question than it looks. This is one of the more common situations we see, because weight, mood, and hormones tend to shift together in midlife. For how the research on GLP-1s and mood is shaping up more broadly, see our post on GLP-1 medications and mental health. This post is narrower: what it means to start one when mood and hormones are already in motion.

Why is starting a GLP-1 different during perimenopause?

Because perimenopause, a mood medication, and a GLP-1 all act on the same systems at once. GLP-1 medications such as Wegovy (semaglutide) reduce appetite and support weight loss by mimicking a gut hormone called glucagon-like peptide-1. Zepbound (tirzepatide) works on two gut-hormone receptors, GLP-1 and GIP, and is often grouped with the GLP-1 medications as shorthand. Perimenopause is the transition leading up to menopause, often spanning several years in the 40s and early 50s, during which estrogen fluctuates rather than simply declining, which can drive mood changes, poor sleep, and shifts in appetite on its own. Add a psychiatric medication working in the background, and a change in how you feel can have more than one explanation. Sorting out which cause is which is the actual clinical work, and it is why we do not treat this as a simple add-on.

What we check before starting a GLP-1 in perimenopause

Before starting, we look at the whole picture, not just the number on the scale, because in midlife weight, mood, hormones, and sleep are usually tangled together. This is the same integrated approach we take across the practice: one clinician reading your lab panel and your medication list, not an algorithm that ships vials. Specifically, we review:

• Whether your mood is currently stable. A medication that changes appetite and weight is easier to interpret when your mood has been steady. If you are mid-episode or just changed psychiatric medications, we may stabilize that first.
• What you already take, and how it might interact. Some psychiatric medications affect appetite or weight, and early GLP-1 nausea can affect whether you take them consistently. We map that out first.
• Your history with food and eating. Because GLP-1s suppress appetite, we ask carefully about any history of restrictive eating or an eating disorder, which changes the plan and is sometimes a reason to hold off.
• Your sleep. Perimenopausal sleep disruption feeds both mood and weight, and no medication overcomes a sleep debt.
• Where you are in the menopause transition. Hot flashes, cycle changes, and night sweats tell us how much of the picture is hormonal, and whether perimenopause care belongs in the plan alongside weight management.
• What you are expecting. We talk honestly about realistic, individualized goals rather than a single target weight.

What we watch for once you start

In the first weeks, we watch your mood in both directions, your energy, and whether side effects are affecting your other medication.

• Mood, up or down. Some women feel better as weight, sleep, and "food noise" improve. Others notice mood dipping. We want to know early either way. A 2025 systematic review and meta-analysis in JAMA Psychiatry found no overall increase in psychiatric side effects, including depression, with GLP-1 medications, but individual responses still vary, which is why we monitor rather than assume.
• Whether eating less is costing you stability. Very low intake in the first weeks can sap energy and affect mood, and it can change how your other medication feels. The same connections we describe in how mental health and weight are linked, through sleep, stress, and cortisol, run in both directions here.
• Whether nausea is disrupting your mood medication. If GI side effects make it hard to take that medication consistently, we address it quickly.
• The bigger changes that come with weight loss. Rapid change can shift how you see yourself and how others respond, and that is worth talking through, not just measuring.

Could perimenopause hide or mimic a GLP-1 side effect?

Yes, and this is the part that gets missed. Perimenopausal mood symptoms can look like a side effect of the GLP-1, and a real GLP-1 effect can be dismissed as "just perimenopause." If your mood shifts two months in, the cause could be the medication, the hormonal transition, your sleep, your eating, or your underlying condition resurfacing. Because we manage both the weight medication and the psychiatric side, we can hold all of those possibilities at once instead of assuming the most convenient one. For how we separate hormonal mood change from depression in the first place, see is it perimenopause or depression.

Women with a prior history of depression are at a substantially higher risk of mood symptoms during perimenopause, which is exactly why we ask about it before adding anything new.

What we will not assume about your mood changes

We will not assume a mood change is caused by the GLP-1, and we will not assume it is not.

• We do not assume perimenopause explains everything.
• We do not assume the goal is the lowest possible number on the scale.

Instead we look at the full picture before changing anything, because pulling the wrong lever can undo progress on the other two fronts. Looking at weight, mood, and hormones together, rather than in separate silos, is the whole premise of how we practice.

When would we hold off or refer out?

A GLP-1 is not right for everyone, and timing matters. We may hold off or refer when there is an active or recent eating disorder, when mood is currently unstable, when there is a medical contraindication, or when the psychiatric picture needs to settle before adding another variable. None of these is necessarily permanent. Often it is "not yet."

What should you ask any prescriber?

Ask these three questions: How will we tell whether a mood change is from this medication, my hormones, or something else? Will you coordinate with whoever manages my mental health medication? What would make you pause treatment? You deserve a clear answer to each.

We do this work under one roof. We prescribe the GLP-1 as part of medical weight loss, including Wegovy and Zepbound, and we manage mental health medication and perimenopause care, so the weight side and the mood side are not two strangers comparing notes. Brand-name GLP-1 only, individualized, and not a candidate for everyone.

Frequently asked questions

This content is for educational purposes only and does not replace medical advice. Treatment decisions are individualized and discussed during your visit. Not everyone is a candidate for GLP-1 therapy, and risks and benefits are reviewed before starting.